house · trading 2023-02-06 → 2023-02-06
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2023-02-06 | GSK | SELL | $1K–$15K | $35.34 | $51.10 2026-10-26 | -44.6% exit |
| 2023-02-06 | F | BUY | $1K–$15K | $13.14 | $14.62 2026-09-04 | +11.3% |
| 2023-02-06 | CCL | SELL | $1K–$15K | $11.87 | $26.86 2026-10-26 | -126.3% exit |
| 2023-02-06 | AMZN | SELL | $1K–$15K | $102.18 | $258.51 2026-09-04 | -153.0% exit |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 4 · AMZN, CCL, F, GSK |
| James B. Renacci | 3 · AMZN, CCL, GSK |
| Josh Gottheimer | 3 · AMZN, CCL, F |
| Thomas H Tuberville | 3 · CCL, F, GSK |
| K. Michael Conaway | 3 · AMZN, F, GSK |
| Alan Armstrong | 3 · AMZN, CCL, F |
| David P. Roe | 3 · AMZN, F, GSK |
| Kenny Marchant | 3 · AMZN, F, GSK |
| Mike Kelly | 3 · AMZN, F, GSK |
| Marie Newman | 3 · AMZN, CCL, F |
| E. Scott Rigell | 3 · CCL, F, GSK |
| Michael T. McCaul | 2 · AMZN, CCL |